Certara - CERT Total Company Value-to-Revenue Ratio

Official company branding of certara.com (CERT)

Cloud delivery of biosimulation software minimizes costs, providing pharma giants with rapid access to tools. The EV/Sales multiple visualizes the asset's market value relative to revenue, where the 4302.13 mark reflects the latest data. The absolute authority of Certara, Inc. (CERT) among regulators makes the company a cornerstone of modern science. A monopoly in the clinical software segment guarantees stability, despite the link to clients' R&D budgets.

CERT: Certara, Inc. EV/Sales Multiple 11/23/2025 - 11/20/2026

Certara Software - analytical breakdowns and key metrics (CERT)

Fundamental company valuation:CERT, certara.com
Original product of Certara Corp

This indicator determines the market value of the business, excluding the impact of debt load on the valuation. The trend of the enterprise value-to-revenue ratio reflects the current expectations of global investors regarding future cash flows. The metric is calculated as the ratio of enterprise value (EV) to annual sales, identifying whether the asset is overbought or undervalued. The stability of this value confirms the status of Certara, Inc. (CERT) as an indispensable technological partner to the FDA. A high premium for intellectual superiority in biosimulation justifies the resilience of this multiple.

Competitor analysis

Enterprise Value-to-Revenue Multiple veeva.com|DOCS (Doximity) - Company Value to Revenue|HQY - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Waystar Inc.|CRVL: Business Value to Revenue|Enterprise Value-to-Revenue Ratio Privia Health Group (PRVA)|EV/Sales Multiple huronconsultinggroup.com (HURN)|EV/Sales Multiple OMCL (Omnicell Inc)|Total Company Value-to-Revenue Ratio GoodRx Inc (GDRX)|Schrodinger Corp - EV/Sales Multiple|Enterprise Value to Sales Volume PHR|OMDA: EV/Sales Multiple|Evolent Health, Inc. - Business Value to Revenue|Enterprise Value-to-Revenue Ratio HealthStream Corp|DH: Business Value to Revenue|Company Value to Revenue CCSI (Consensus)|Total Company Value-to-Revenue Ratio Agilon Health|EV/Sales Multiple ABSI (Absci)|soyoung.com (SY) - Enterprise Value-to-Revenue Multiple|NRC - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Spok Holdings Inc SPOK|OPRX (OptimizeRx) - Company Value to Revenue|TBRG - Total Company Value-to-Revenue Ratio|Company Value to Revenue SLP|Enterprise Value-to-Revenue Multiple sophiagenetics.com SOPH|EV/Sales Multiple HCAT|CCLD (CareCloud Inc.) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Research Solutions Inc. RSSS|DLHC - Company Value to Revenue|ONMD - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Scienture Holdings Inc SCNX|HCTI: EV/Sales Multiple|Company Value to Revenue Ratio ISPC|BFRG (Bullfrog AI) - EV/Sales Multiple|Company Value to Revenue SCWorx Inc (WORX)|EV/Sales Multiple MSPR|ICCT - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple MEDS (TRxADE Health Corp)|Enterprise Value-to-Sales Ratio Orgenesis|R1 RCM - EV/Sales Multiple|Business Value to Revenue SHCR (Sharecare, Inc)|STRM (Streamline Health Solutions Inc.) - Company Value to Revenue|Enterprise Value-to-Revenue Multiple syrahealth.com (SYRA)|Company Value to Revenue AMEH|MODN: Business Value to Revenue|Company Value to Revenue NXGN (NextGen Healthcare)